論文

論文業績のFull listはこちら(PubMedへのリンクです。著者名で検索しているため誤りを含む可能性があります。)

 

2020

Iwadate M, Mitsutake N, Matsuse M, Fukushima T, Suzuki S, Matsumoto Y, Ookouchi C, Mizunuma H, Nakamura I, Nakano K, Sakamoto A, Hirokawa M, Ito M, Naganuma H, Hashimoto Y, Shimura H, Yamashita S, Suzuki S.

The clinicopathological results of thyroid cancer with BRAFV600E mutation in the young population of Fukushima.

J Clin Endocrinol Metab, 2020 Aug Epub [PubMed]

Nakazawa Y, Hara Y, Oka Y, Komine O, van den Heuvel D, Guo C, Daigaku Y, Isono M, He Y, Shimada M, Kato K, Jia N, Hashimoto S, Kotani Y, Miyoshi Y, Tanaka M, Sobue A, Mitsutake N, Suganami T, Masuda A, Ohno K, Nakada S, Mashimo T, Yamanaka K, Luijsterburg MS, Ogi T.

Ubiquitination of DNA Damage-Stalled RNAPII Promotes Transcription-Coupled Repair.

Cell, 180: 1228-1224.e24, 2020 [PubMed]

2019

Suzuki K, Akita S, Yoshimoto H, Ohtsuru A, Hirano A, Yamashita S.

Biological Features Implies Potential Use of Autologous Adipose-Derived Stem/Progenitor Cells in Wound Repair and Regenerations for the Patients with Lipodystrophy.

Int J Mol Sci, 20: 5505, 2019 [PubMed]

Suzuki K, Saenko V, Yamashita S, Mitsutake N.

Radiation-Induced Thyroid Cancers: Overview of Molecular Signatures.

Cancers, 11: 1290, 2019 Review [PubMed]

Tanaka A, Matsuse M, Saenko V, Nakao T, Yamanouchi K, Sakimura C, Yano H, Nishihara E, Hirokawa M, Suzuki K, Miyauchi A, Eguchi S, Yoshiura KI, Yamashita S, Nagayasu T, Mitsutake N.

TERT mRNA Expression as a Novel Prognostic Marker in Papillary Thyroid Carcinomas.

Thyroid, 29: 1105-1114, 2019 [PubMed]

Meng Z, Matsuse M, Saenko V, Yamashita S, Ren P, Zheng X, Jia Q, Tan J, Li N, Zheng W, Zhao L, Mitsutake N.

TERT promoter mutation in primary papillary thyroid carcinoma lesions predicts absent or lower 131 i uptake in metastases.

IUBMB Life, 71: 1030-1040, 2019 [PubMed]

Saijo H, Suzuki K, Yoshimoto H, Imamura Y, Yamashita S, Tanaka K.

Paracrine Effects of Adipose-Derived Stem Cell Promote Lymphangiogenesis in Irradiated Lymphatic Endothelial Cells.

Plast Reconstr, 143: 1189e-1200e, 2019 [PubMed]

Shiraiwa K, Matsuse M, Nakazawa Y, Ogi T, Suzuki K, Saenko V, Xu S, Umezawa K, Yamashita S, Tsukamoto K, Mitsutake N.

JAK/STAT3 and NF-κB Signaling Pathways Regulate Cancer Stem-Cell Properties in Anaplastic Thyroid Cancer Cells.

Thyroid, 29: 674-682, 2019 [PubMed]

Suzuki S, Bogdanova TI, Saenko VA, Hashimoto Y, Ito M, Iwadate M, Rogounovitch TI, Tronko MD, Yamashita S.

Histopathological analysis of papillary thyroid carcinoma detected during ultrasound screening examinations in Fukushima.

Cancer Sci, 110: 127-133, 2019 [PubMed]

2018

Bogdanova TI, Saenko VA, Brenner AV, Zurnadzhy LY, Rogounovitch TI, Likhtarov IA, Masiuk SV, Kovgan LM, Shpak VM, Thomas GA, Chanock SJ, Mabuchi K, Tronko MD, Yamashita S.

Comparative Histopathologic Analysis of "Radiogenic" and "Sporadic" Papillary Thyroid Carcinoma: Patients Born Before and After the Chernobyl Accident.

Thyroid, 28: 880-890, 2018 [PubMed]

Todorović L, Stanojević B, Mandušić V, Petrović N, Živaljević V, Paunović I, Diklić A, Saenko V, Yamashita S.

Expression of VHL tumor suppressor mRNA and miR-92a in papillary thyroid carcinoma and their correlation with clinical and pathological parameters.

Med Oncol, 35: 17, 2018 [PubMed]

Yamashita S, Suzuki S, Suzuki S, Shimura H, Saenko V.

Lessons from Fukushima: Latest Findings of Thyroid Cancer After the Fukushima Nuclear Power Plant Accident.

Tyroid, 28: 11-22, 2018 [PubMed]

2017

Khvostunov IK, Saenko VA, Krylov V, Rodichev A, Yamashita S

Cytogenetic biodosimetry and dose-rate effect after radioiodine therapy for thyroid cancer

Radiat Environ Biophys, 56: 213-226, 2017 [PubMed]

Suzuki K

Analyzing ATM Function by Electroporation of Endonucleases and Immunofluorescence Microscopy

Methods Mol Biol, 1599: 85-96, 2017 [PubMed]

Iyama K, Matsuse M, Mitsutake N, Rogounovitch T, Saenko VA, Suzuki K, Ashizawa M, Ookouchi C, Suzuki S, Mizunuma H, Fukushima T, Suzuki S, Yamashita S

Identification of Three Novel Fusion Oncogenes, SQSTM1/NTRK3, AFAP1L2/RET, and PPFIBP2/RET in Thyroid Cancers of Young Patients in Fukushima

Thyroid, 27: 811-818, 2017 [PubMed]

Yamashita S, Saenko V

What Is the "Screening Effect" Six Years After the Fukushima Nuclear Power Plant Accident?

Thyroid, 27: 595-596, 2017[PubMed]

Matsuse M, Yabuta T, Saenko V, Hirokawa M, Nishihara E, Suzuki K, Yamashita S, Miyauchi A, Mitsutake N

TERT promoter mutations and Ki-67 labeling index as a prognostic marker of papillary thyroid carcinomas: combination of two independent factors

Sci Rep, 7: 41752, 2017 [PubMed]

Nikitski A, Rogounovitch T, Bychkov A, Takahashi M, Yoshiura KI, Mitsutake N, Kawaguchi T, Matsuse M, Drozd VM, Demidchik YE, Nishihara E, Hirokawa M, Miyauchi A, Rubanovich AV, Matsuda F, Yamashita S, Saenko VA

Genotype analyses in the Japanese and Belarusian populations reveal independent effects of rs965513 and rs1867277 but do not support the role of FOXE1 polyalanine tract length in conferring risk for papillary thyroid carcinoma

Thyroid, 27: 224-235, 2017 [PubMed]